Novelty Nobility

Seongnam, South Korea · Founded 2017 · Privately Held (backing)

Operator of a biotech company intended to develop antibodies and antibody-drug conjugates to overcome drug resistance. Novelty Nobility is based in Seongnam, South Korea and was founded in 2017. Its last known valuation is $10.8 million. It has raised $60.8 million.

Last price · $/share
—
Implied valuation
$10.8M
Total raised
$60.8M
Last round
—

Who backs Novelty Nobility?

29 investors
InvestorType
KB InvestmentVenture capital
Mirae Asset CapitalVenture capital
Shinhan Venture InvestmentVenture capital
Johnson & Johnson Innovation - JLABSOther
KDB CapitalOther
DAYLI PartnersVenture capital
NH Investment & SecuritiesOther
K2 Investment PartnersVenture capital
Ulmus InvestmentVenture capital
Medici InvestmentVenture capital
+ 19 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Novelty Nobility investors

29 investors are on record for Novelty Nobility, including KB Investment, Mirae Asset Capital, Shinhan Venture Investment and Johnson & Johnson Innovation - JLABS. By type, the record holds 8 venture capital firms and 1 hedge fund.

Free account
More of Novelty Nobility with a free account
  • ·The complete investor list: 29 names
  • ·Watch Novelty Nobility: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 29 firms already write checks for companies like Novelty Nobility. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View